Trachsel, CH
Alain Trachsel, Geneva 8 CH
Patent application number | Description | Published |
---|---|---|
20150045274 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE PERFUMING MOLECULES - The present invention relates to the field of perfumery. More particularly, it concerns compounds comprising at least one β-thio carbonyl or nitrile moiety capable of liberating an active molecule selected from an α,β-unsaturated ketone, aldehyde or nitrile. The present invention concerns also the use of said compounds in perfumery as well as the perfuming compositions or perfumed articles comprising the invention's compounds. (I) wherein: a) m represents an integer from 1 to 6; b) Pro represents a hydrogen atom or a group susceptible of generating an odoriferous α,β-unsaturated ketone, aldehyde or nitrile and is represented by the formulae (II) or (II′) in which the wavy line indicates the location of the bond between said Pro and the sulfur atom S; and at least one of the Pro groups is of the formula (II) or (II′). | 02-12-2015 |
Alain Trachsel, Geneva CH
Patent application number | Description | Published |
---|---|---|
20160108346 | MICROCAPSULES CONTAINING A GAS-GENERATING PHOTOLABILE KETOACID OR KETOESTER AND USES THEREOF - The present invention relates to water-dispersable microcapsules comprising an oil phase, e.g. a perfume, containing a photolabile α-ketoacid or α-ketoester capable of generating a gas upon exposure to light. The gas is able to cause an extension or the breaking of the microcapsule allowing the release of the oil phase and thus increasing the long-lastingness of the odor perception. The present invention concerns also the use of said microcapsules in perfumery as well as the perfuming compositions or perfumed articles comprising the invention's microcapsules to provide a prolonged release of fragrant molecules. | 04-21-2016 |
Daniel Trachsel, Bubendorf CH
Patent application number | Description | Published |
---|---|---|
20100016401 | 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES - The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R | 01-21-2010 |
20100204285 | TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES - The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R | 08-12-2010 |
20110009401 | 2-AZA-BICYCLO[2.2.1]HEPTANE DERIVATIVES - The invention relates to novel 2-aza-bicyclo[2.2.1]heptane derivatives of formula (I), | 01-13-2011 |
20110009461 | 2-AZA-BICYCLO[3.3.0]OCTANE DERIVATIVES - The invention relates to 2-aza-bicyclo[3.3.0]octane derivatives of Formula (I) wherein A, B, and R | 01-13-2011 |
20110039857 | PIPERIDINE AND PYROOLIDINE COMPOUNDS - The invention relates to piperidine and pyrrolidine compounds of formula (I) | 02-17-2011 |
20110124636 | 2-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - The invention relates to novel 2-aza-bicyclo[3.1.0]hexane derivatives of Formula (I) wherein A, B, n and R | 05-26-2011 |
Daniel Trachsel, Allschwil CH
Patent application number | Description | Published |
---|---|---|
20110212968 | PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES - The invention relates to novel phenethylamide derivatives and their wherein A, B, R | 09-01-2011 |
Eveline Trachsel, Baden CH
Patent application number | Description | Published |
---|---|---|
20110256091 | Antibody-Targeted Cytokines for Therapy - The present invention relates to fusion proteins comprising an antibody, functional fragment or functional derivative thereof having specific binding affinity to either the extracellular domain of oncofetal fibronectin (ED-B) or at least one of the extracellular domains of oncofetal tenascin fused to a cytokine selected from the group consisting of IL-10, IL15, IL-24 and GM-CSF, functional fragments and functional derivatives thereof. The invention is also directed to the use of at least one of said fusion proteins for the manufacture of a medicament. In particular, the invention concerns the use of said medicament for the treatment of tumours or chronic inflammatory diseases such as atherosclerosis, arthritis and psoriasis. | 10-20-2011 |
Eveline Trachsel, Hausen CH
Patent application number | Description | Published |
---|---|---|
20150030536 | ANTIGEN ASSOCIATED WITH LUNG CANCERS AND LYMPHOMAS - The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the treatment of lung cancer and lymphoma. | 01-29-2015 |
Eveline Trachsel, Zurich CH
Patent application number | Description | Published |
---|---|---|
20100183506 | ANTIGEN ASSOCIATED WITH LUNG CANCERS AND LYMPHOMAS - The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the treatment of lung cancer and lymphoma. | 07-22-2010 |
20100215615 | IMMUNOCYTOKINES FOR CANCER TREATMENT IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS - This invention relates to the treatment of cancer using anti-cancer agents, such as doxorubicin or paclitaxel, in combination with antibody-interleukin 2 (IL2) conjugates which target tenascin-C. | 08-26-2010 |
20100260707 | ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS - The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the detection and treatment of rheumatoid arthritis. | 10-14-2010 |
20120107270 | Immunocytokines In Combination With Anti-ErbB Antibodies For The Treatment Of Cancer - This invention relates to the treatment of cancer using anti-ErbB antibodies, such as cetuximab or trastuzumab, in combination with antibody-interleukin 2 (IL2) conjugates which target tenascin-C. | 05-03-2012 |
20120244114 | ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS - The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the detection and treatment of rheumatoid arthritis. | 09-27-2012 |
20130108581 | Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic Agents | 05-02-2013 |
20140341844 | IMMUNOCYTOKINES IN COMBINATION WITH ANTI-ERBB ANTIBODIES FOR THE TREATMENT OF CANCER - This invention relates to the treatment of cancer using anti-ErbB antibodies, such as cetuximab or trastuzumab, in combination with antibody-interleukin 2 (IL2) conjugates which target tenascin-C. | 11-20-2014 |
Mathis Trachsel, Luzern CH
Nicolas Trachsel, Bex CH
Patent application number | Description | Published |
---|---|---|
20110109076 | INTAGLIO PRINTING INK COMPRISING DENDRIMERS - An ink for the engraved copperplate intaglio printing Hyperbranched polyesters inks is disclosed, which comprises high-molecular-weight dendritic polymer as a binder component. Inks comprising such polymer can be formulated so as to contain a significantly reduced amount of organic solvent (volatile organic components, VOC) whilst still being in the appropriate viscosity range required by the intaglio printing process. The printed and cured intaglio ink of the present invention has improved chemical and mechanical resistance properties. | 05-12-2011 |
Thomas Trachsel, Berne CH
Patent application number | Description | Published |
---|---|---|
20120288107 | TEST SYSTEM FOR EVALUATING FEEDBACK PERFORMANCE OF A LISTENING DEVICE - A test system for evaluates acoustic feedback characteristics of a listening device by changing the transfer function of the signal path from an acoustic output to an acoustic input of the listening device. A variable filter comprises an acoustic input, an acoustic output, and a control unit for changing a transfer function of the filter. First and/or second acoustic propagation elements propagate acoustic sound, the first acoustic propagation element acoustically connecting the acoustic output of the listening device with the acoustic input of the variable filter, the second acoustic propagation element acoustically connecting the acoustic output of the variable filter with the acoustic input of the listening device; wherein the system is configured to allow a determination of acoustic feedback or a level of acoustic feedback of the listening device at different frequencies. | 11-15-2012 |